AEGR

Aegerion Pharmaceuticals, Inc. News Headlines

$21.81
*  
0.44
2.06%
Get AEGR Alerts
*Delayed - data as of Nov. 24, 2014  -  Find a broker to begin trading AEGR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    AEGR After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Aegerion to Acquire Myalept, Boost Portfolio - Shares Up - Analyst Blog
11/11/2014 12:52:00 PM - Zacks.com


AstraZeneca (AZN) Misses on Q3 Earnings, Raises Guidance - Analyst Blog
11/7/2014 3:20:00 PM - Zacks.com


Commit To Buy Aegerion Pharmaceuticals At $15, Earn 17% Using Options
11/6/2014 11:46:14 AM - BNK Invest


Why Aegerion Pharmaceuticals, Inc. Stock Collapsed in October
11/6/2014 8:36:02 AM - Motley Fool


Aegerion Buys Rare Disease Therapy, Seeking Path Out of Current Troubles
11/6/2014 7:55:00 AM - TheStreet


AstraZeneca Profit Declines, Lifts Full Year Forecast
11/6/2014 4:54:00 AM - RTT News


AstraZeneca To Sell Myalept To Aegerion - Quick Facts
11/6/2014 2:52:00 AM - RTT News


Sector Update: Health Care Stocks Surging Today; Aegerion Pharmaceuticals Rocked by Revenue Miss
10/31/2014 12:55:23 PM - MT Newswires


Sector Update: Health Care
10/31/2014 12:40:15 PM - MT Newswires


Mid-Day Market Update: GoPro Jumps On Upbeat Results; Tempur Sealy Shares Dip
10/31/2014 12:34:21 PM - Benzinga


Will Insiders Be Tempted To Buy More AEGR At The New 52-Week Low?
10/31/2014 12:14:03 PM - BNK Invest


Why Shares of Aegerion Phaemaceuticals, Inc. Were Obliterated Today
10/31/2014 11:34:02 AM - Motley Fool


Aegerion Q3 Loss Wider than Expected, 2014 View Lowered - Analyst Blog
10/31/2014 10:32:00 AM - Zacks.com


Mid-Morning Market Update: Markets Open Higher; Clorox Earnings Top Street View
10/31/2014 10:06:28 AM - Benzinga


Aegerion Pharmaceuticals Inc. (AEGR) Has Dropped To A New Low After Outlook Cut
10/31/2014 9:37:00 AM - RTT News


Aegerion Pharmaceuticals (AEGR) Stock Downgraded Today at Jefferies
10/31/2014 9:09:00 AM - TheStreet


Analysts' Actions: Aegerion, Atmel, Avon, Seattle Genetics, More
10/31/2014 9:01:00 AM - TheStreet


Aegerion Pharma Cuts Full Year Revenue View; Stock Down
10/31/2014 1:32:00 AM - RTT News


Aegerion Pharma Q3 Loss Narrows; Cuts FY14 Product Sales Guidance
10/30/2014 7:13:00 PM - RTT News


Aegerion Problems Mount With Poor Quarter and Reduced Guidance
10/30/2014 5:07:00 PM - TheStreet


Point72 Asset Management’s position in Aegerion Pharmaceuticals
10/27/2014 5:00:00 PM - Market Realist


Will Aegerion (AEGR) Disappoint This Earnings Season? - Analyst Blog
10/27/2014 4:40:00 PM - Zacks.com


Aegerion, Seattle Genetics CEOs Accused in Suit of Cocaine Use
10/27/2014 10:24:00 AM - TheStreet


Point72 Asset Management increases stake in Bloomin’ Brands
10/24/2014 1:00:00 PM - Market Realist


Point72 Asset Management increases position in AMC Entertainment
10/24/2014 9:00:00 AM - Market Realist